Business Segments Guizhou Bailing Group Pharmaceutical Co., Ltd.
Stocks
002424
CNE100000PY3
Pharmaceuticals
|
End-of-day quote
Shenzhen S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 4.580 CNY | +0.66% |
|
-0.22% | +5.29% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Industrial | 2.88B | 3.04B | 3.47B | 2.99B | 2.49B | |||||
Total Assets | 6.8B | 6.86B | 7.12B | 6.79B | 6.01B | |||||
Commercial Business | 824M | 1.17B | 1.69B | 1.45B | 1.13B | |||||
Total Assets | 497M | 1.04B | 1.22B | 1.3B | 1.36B | |||||
Medical Institutions | 60.97M | 51.78M | 60.08M | 64.22M | 67.86M | |||||
Total Assets | 130M | 109M | 97.3M | 70.01M | 58.98M | |||||
Others | 20.96M | 27.25M | 45.43M | 36.31M | 22.8M | |||||
Total Assets | 327M | 328M | 326M | 323M | 320M | |||||
Intersegment Elimination | -676M | -744M | -1B | -712M | -658M | |||||
Total Assets | -1.27B | -1.44B | -1.42B | -1.35B | -1.55B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
China | 3.11B | 3.54B | 4.26B | 3.83B | 3.05B | |||||
Total Assets | 6.49B | 6.89B | 7.35B | 7.13B | 6.2B | |||||
Interest Expense | -116M | -102M | -92.71M | -85.83M | -61.78M | |||||
Income Tax Expense | 31.07M | 23.09M | -80.61M | 30.14M | 144M | |||||
D&A | 107M | 116M | 116M | 115M | 122M | |||||
CAPEX | -426M | -68.45M | -104M | -42.02M | -125M | |||||
Net Income | 124M | 138M | -415M | 33.62M | -104M | |||||
EBT | 148M | 159M | -493M | 66.91M | 40.47M | |||||
Operating Income | 181M | 156M | -484M | 4.35M | 78.74M |
Select your edition
All financial news and data tailored to specific country editions
